Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dachundou No Sugar Added Soymilk for Lipid Modulation
Sponsor: National Taiwan Sport University
Summary
Cardiovascular disease is one of the leading causes of death worldwide, and high cholesterol is a major risk factor. Diet is known to play an important role in managing blood lipids. Soy milk is a common plant-based drink rich in protein and isoflavones, which may help lower cholesterol and improve heart health. This clinical trial will evaluate whether daily consumption of Dachundou No Sugar Added Soymilk can help reduce cholesterol levels in adults with elevated total cholesterol (≥200 mg/dL). A total of 50 participants aged 18-65 will be recruited. Participants will drink two bottles of soymilk per day (375 mL each, total 750 mL) for 8 weeks. During the study, researchers will measure cholesterol, blood pressure, body weight, waist circumference, and other health indicators. The results will help determine whether Dachundou No Sugar Added Soymilk can improve blood lipid levels and contribute to cardiovascular health.
Official title: A Study on the Lipid-Modulating and Health Benefits of Dachundou No Sugar Added Soymilk in Humans
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-09-15
Completion Date
2026-08-31
Last Updated
2025-09-16
Healthy Volunteers
Yes
Interventions
Dachundou No Sugar Added Soymilk
Participants will consume two bottles of Dachundou No Sugar Added Soymilk daily (375 mL each; total 750 mL per day) for 8 consecutive weeks. The product is packaged in 375 mL cartons and made from non-GMO soybeans, containing approximately 4.2 g of soy protein per 100 mL. The soymilk is unsweetened and stored at 0-7°C.
Locations (1)
National Taiwan Sport University
Taoyuan District, Taiwan